Since ligand requirements for AIM2 inflammasome are quite permissive [12, 13], we are interested to define whether the anti-tumor effect of AIM2 in HCC cells is mediated by AIM2 inflammasome. Here, AIM2 is linked to hepatocellular carcinoma.